Valentina Orioli, Lucio Careddu, Marianna Berardi, Valeria Francesca Mangerini, Francesco Dimitri Petridis, Gabriele Egidy Assenza, Marta Agulli, Andrea Donti, Gaetano Domenico Gargiulo, Emanuela Angeli
{"title":"Additional pulmonary blood flow strategy at bidirectional Glenn: impact on pulmonary artery growth and long-term Fontan outcomes.","authors":"Valentina Orioli, Lucio Careddu, Marianna Berardi, Valeria Francesca Mangerini, Francesco Dimitri Petridis, Gabriele Egidy Assenza, Marta Agulli, Andrea Donti, Gaetano Domenico Gargiulo, Emanuela Angeli","doi":"10.1093/icvts/ivag299","DOIUrl":"https://doi.org/10.1093/icvts/ivag299","url":null,"abstract":"<p><strong>Objective: </strong>Management of additional pulmonary blood (APBF) flow during staged palliation toward Fontan completion remains debated, however it may influence long-term outcomes. To assess whether APBF promotes pulmonary artery (PA) growth before Fontan completion and whether different APBF strategies correlate with distinct long-term outcomes.</p><p><strong>Methods: </strong>A retrospective single-center study was conducted on 205 patients undergoing Fontan completion between 1989 and 2024. Of these, 98 had APBF (83 antegrade APBF, 15 persistent mBT-shunt). Long-term outcomes included survival and freedom from PA stenting.</p><p><strong>Results: </strong>Pre-Fontan PA diameters were larger in patients with APBF than in those without APBF: LPA 10.70 ± 3.76 mm vs 8.80 ± 3.43 mm (p < 0.0001) and RPA 12.18 ± 3.65 mm vs 10.99 ± 3.65 mm (p = 0.032). Within the APBF group, antegrade flow was associated with larger PA diameters than persistent mBT-shunt: LPA 11.12 ± 3.70 mm vs 9.01 ± 3.51 mm (p < 0.0001) and RPA 12.56 ± 3.67 mm vs 11.12 ± 3.59 mm (p = 0.009). Overall survival was higher in patients with APBF at 20 years (97.5% [95% CI, 83.6%-99.6%] vs 88.2% [95% CI, 75.9%-94.4%], p = 0.032). Freedom from PA stenting at 10 years was 98% (95% CI, 81.7%-96.1%) in patients without APBF, 95% (95% CI, 86.3%-98.5%) in those with antegrade APBF, and 78% (95% CI, 45.9%-92.3%) in those with persistent mBT-shunts.</p><p><strong>Conclusions: </strong>APBF appears to promote PA growth without increasing pulmonary pressures, but both APBF strategies may be associated with branch PA stenosis, with different timing according to flow type.</p>","PeriodicalId":73406,"journal":{"name":"Interdisciplinary cardiovascular and thoracic surgery","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2026-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149382061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Patrick Deniz Hurley, Guillermo Rodriguez Dávila, David Gómez de Antonio, Maria-Teresa Gomez-Hernandez, Joshil Lodhia, Marcelo Jimenez, Marco Nardini, Nuria Novoa, Peter Tcherveniakov, Elaine Teh, Alessandro Brunelli
{"title":"Baseline predictors of post-treatment diffusion capacity after neoadjuvant chemo-immunotherapy in non-small-cell lung cancer: development and external validation of a clinical prediction model.","authors":"Patrick Deniz Hurley, Guillermo Rodriguez Dávila, David Gómez de Antonio, Maria-Teresa Gomez-Hernandez, Joshil Lodhia, Marcelo Jimenez, Marco Nardini, Nuria Novoa, Peter Tcherveniakov, Elaine Teh, Alessandro Brunelli","doi":"10.1093/icvts/ivag292","DOIUrl":"https://doi.org/10.1093/icvts/ivag292","url":null,"abstract":"<p><strong>Objectives: </strong>Routine repetition of pulmonary function tests (PFTs) following neoadjuvant chemo-immunotherapy is standard but may be redundant in selected patients. We aimed to develop and externally validate a multivariable model to predict post-treatment carbon monoxide lung diffusion capacity (DLCO), with the objective of identifying patients at low predicted risk of clinically important post-treatment impairment in whom selective omission of repeat testing could potentially be considered.</p><p><strong>Methods: </strong>A predictive model was derived from 106 patients with locally advanced non-small cell lung cancer (NSCLC) undergoing neoadjuvant chemo-immunotherapy. Multivariable regression with backward stepwise elimination was used to test candidate predictors. The model was validated on an external cohort of 60 patients. Agreement was assessed using locally weighted scatterplot smoothing (Lowess) curves and misclassification rates relative to a clinically relevant threshold of DLCO<60%.</p><p><strong>Results: </strong>The final model retained four independent predictors: Baseline DLCO (p < 0.001), Age (p < 0.001), Programmed death-ligand 1 (PD-L1) expression (p = 0.043), and Smoking status (p = 0.10). Applied to the external validation cohort (n = 60), the model demonstrated a median predicted DLCO of 66% (IQR 59-79) versus an observed DLCO of 73% (IQR 59-83), and Lowess curves indicated a stable relationship across the data range. The model correctly identified 100% of patients with an observed post-treatment DLCO<60% by using a predicted threshold of < 65%. All patients with a predicted DLCO>65% had an observed DLCO>60%.</p><p><strong>Conclusions: </strong>We developed and externally validated a clinical model that reliably predicts post-neoadjuvant DLCO. The model may help identify asymptomatic patients at low likelihood of a post-treatment DLCO <60% in whom repeat PFT assessment could potentially be omitted. Prospective validation is required before this approach can be recommended in routine clinical practice.</p>","PeriodicalId":73406,"journal":{"name":"Interdisciplinary cardiovascular and thoracic surgery","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149328106","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Chang Li, Tianren Jin, Diego Gonzalez-Rivas, Jun Zhao
{"title":"Uniportal robotic sleeve tracheal and carinal resection with bronchial flap reconstruction.","authors":"Chang Li, Tianren Jin, Diego Gonzalez-Rivas, Jun Zhao","doi":"10.1093/icvts/ivag278","DOIUrl":"https://doi.org/10.1093/icvts/ivag278","url":null,"abstract":"<p><p>Carinal reconstruction remains technically challenging because of complex airway management and anastomotic tension. A 42-year-old man with adenoid cystic carcinoma extending from the distal trachea to the right main bronchus underwent uniportal robotic-assisted right upper lobectomy and sleeve tracheocarinal resection with pedicled right upper lobe bronchial flap reconstruction under veno-venous extracorporeal membrane oxygenation support. This case suggests that this approach may be technically feasible for selected eccentric, complex tracheocarinal tumors.</p>","PeriodicalId":73406,"journal":{"name":"Interdisciplinary cardiovascular and thoracic surgery","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149336277","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
J H Jedrzejczyk, M Hazekamp, M Palmen, S Nemoto, J Honge, J Hjortnaes, T D Jeppesen, J M Hasenkam
{"title":"Repair of the Anterior Mitral Leaflet in a Growing Porcine Model Using a Partially Resorbable Knitted Patch.","authors":"J H Jedrzejczyk, M Hazekamp, M Palmen, S Nemoto, J Honge, J Hjortnaes, T D Jeppesen, J M Hasenkam","doi":"10.1093/icvts/ivag229","DOIUrl":"10.1093/icvts/ivag229","url":null,"abstract":"<p><p>Mitral valve repair using patch materials is frequently limited by degeneration, inflammation, and calcification, particularly in younger patients. This study evaluated the feasibility and functional durability of a partially resorbable hybrid warp-knitted bioscaffold (Synfolium, Teijin Medical Technologies, Osaka, Japan) for mitral reconstruction in a growing porcine model. In a 6-month-old Danish Landrace pig (80 kg), the mitral A2 segment was replaced with a 10 × 30 mm Synfolium patch via left thoracotomy. Postoperative echocardiography demonstrated normal valve function. After 181 days, echocardiography was repeated prior to sacrifice, followed by macroscopic inspection, histological analysis, and high-resolution micro-computed tomography (micro-CT) of the explanted valve. During follow-up, the animal grew to 159 kg. Six-month echocardiography demonstrated preserved valve function with minimal regurgitation despite a 62% increase in annular diameter. Macroscopically, the patch was fully integrated and endothelialized, with no signs of structural failure. Histology demonstrated low-grade chronic inflammation confined to suture interfaces, with no fibrosis or inflammation within the patch matrix. No calcification was identified on histology or micro-CT. In this growing porcine model, mitral leaflet reconstruction using a Synfolium patch preserved valve competence and resisted calcification over 6 months despite substantial cardiac growth. These findings are encouraging, although repetition of the study is required to confirm the results.</p>","PeriodicalId":73406,"journal":{"name":"Interdisciplinary cardiovascular and thoracic surgery","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148946156","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
William Herrik Nielsen, Finn Gustafsson, Steven Shaw, Jens Garbade, Michiel Morshuis, Daniel Zimpfer, Jacob Lavee, Laura Walker, Carlye Kraemer, Carlo Gazzola, Diyar Saeed
{"title":"Six-Minute Walk Distance and Long-Term Outcomes in Contemporary Left Ventricular Assist Device Recipients: The ELEVATE Registry.","authors":"William Herrik Nielsen, Finn Gustafsson, Steven Shaw, Jens Garbade, Michiel Morshuis, Daniel Zimpfer, Jacob Lavee, Laura Walker, Carlye Kraemer, Carlo Gazzola, Diyar Saeed","doi":"10.1093/icvts/ivag241","DOIUrl":"10.1093/icvts/ivag241","url":null,"abstract":"<p><strong>Objectives: </strong>This study aimed to assess the prognostic value of six-minute walk distance (6MWD) in stable HeartMate 3 (HM3) recipients.</p><p><strong>Methods: </strong>Data from patients with available 6MWD at 6 months post-implant were obtained from the prospective, multicentre ELEVATE registry. Overall survival and adverse event rates were analysed using Cox regression models adjusted for age and sex, with 6MWD as a continuous predictor, and stratified by median distance (350 m).</p><p><strong>Results: </strong>Six-minute walk distance at 6 months was available in 194 HM3 recipients. Patients walking < median were older (57 vs 52 years, P = .002), had more comorbidities, and reported lower quality of life. Six-minute walk distance correlated positively with haemoglobin (r = 0.20, P = .006) and EuroQoL-5 Dimensions visual analogue scale (EQ-5D VAS) (r = 0.23, P = .004), and inversely with New York Heart Association (NYHA) class (r = -0.47, P < .0001). Kaplan-Meier analyses of patients walking < or ≥ 350 m showed no significant differences in survival (log-rank P = .379), right heart failure (HF) (P = .334), or rehospitalization (P = .243), while survival free from haemocompatibility-related adverse events differed significantly, although marginally (P = .049). Cox models confirmed that 6MWD had no independent prognostic value for mortality (HR 0.98, 95% CI, 0.96-1.01, P = .26) or secondary outcomes. However, patients with < median 6MWD experienced higher rates of major bleeding (Incidence rate ratio (IRR) 2.88, P < .001), major infection (IRR 2.14, P < .0001), and renal dysfunction (IRR 4.78, P = .033).</p><p><strong>Conclusions: </strong>Shorter 6MWD 6 months after HM3 implantation was associated with a higher risk of some adverse events (AEs) but was not prognostic for mortality, HF recurrence, or rehospitalization risk. The prognostic value of 6MWD in HF patients without circulatory support cannot be extrapolated to patients treated with current left ventricular assist devices (LVADs).</p><p><strong>Clinical trial registration number: </strong>ClinicalTrials.gov Identifier: NCT02497950.</p>","PeriodicalId":73406,"journal":{"name":"Interdisciplinary cardiovascular and thoracic surgery","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13730604/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148946182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A Digital, Patient-Centred Carepath for Cardiac Surgical Care With Continuous Remote Patient Monitoring.","authors":"Guylian Stevens, Jelle Fleerakkers, Jules François, Phillippe Ballaux, Koen Cathenis, Pascal Verdonck","doi":"10.1093/icvts/ivag253","DOIUrl":"10.1093/icvts/ivag253","url":null,"abstract":"<p><p>Postoperative complications and readmissions remain common after cardiac surgery, and intermittent manual vital-sign checks leave patients unmonitored for much of the recovery period. We implemented a phygital care pathway combining enhanced recovery after surgery (ERAS) protocols, and 21-day continuous remote monitoring (heart rate, respiratory rate, temperature, blood pressure, and oxygen saturation) with daily review and escalation to a cardiac surgeon when indicated. Quality of recovery (QoR-15) was assessed on preoperative days -1 and postoperative days 3 and 7, and patient-reported experience measurement (PREM) on day 30. Outcomes in 221 monitored patients (May-November 2025) were compared, retrospectively, with a historical, non-monitored cohort of 206 patients. In the monitored patients, a good-to-excellent QoR increase from 25% to 56% between days 3 and 7 was noticed. Seventy-five patients (34%) required 98 interventions, most commonly primary-care referral or medication adjustment. Thirty-day readmission (12.7% vs 12.1%, Fisher P = .88) and mortality (0.45% vs 1.4%, Fisher P = .36) did not differ significantly from the control cohort; the monitored group was significantly younger (66.7 vs 70.1 years, P = .0004), reflecting probable selection bias from smartphone and digital-literacy eligibility criteria. Patient-reported experience measurement scores were high (>91%). This pilot demonstrates the feasibility of a digital, patient-centred cardiac surgical pathway; readmission and mortality findings are hypothesis-generating and require prospective confirmation.</p>","PeriodicalId":73406,"journal":{"name":"Interdisciplinary cardiovascular and thoracic surgery","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13730546/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148957382","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Nabil Hussein, Branko Mimic, Mats Synnergren, Nagarajan Muthialu, Victor Tsang, Martin Kostolny
{"title":"Long-Term Outcomes After Supravalvar Aortic Stenosis Repair: Impact of Residual Haemodynamics on Reintervention.","authors":"Nabil Hussein, Branko Mimic, Mats Synnergren, Nagarajan Muthialu, Victor Tsang, Martin Kostolny","doi":"10.1093/icvts/ivag230","DOIUrl":"10.1093/icvts/ivag230","url":null,"abstract":"<p><strong>Objectives: </strong>Surgical repair of supravalvar aortic stenosis (SVAS) provides excellent early outcomes; however, late reintervention remains common. The determinants of left ventricular outflow tract (LVOT) failure, particularly the role of residual haemodynamics, remain incompletely defined. We sought to identify predictors of LVOT reintervention in a contemporary cohort.</p><p><strong>Methods: </strong>A retrospective study of consecutive patients aged <18 years undergoing SVAS repair between 2005 and 2024 was performed. Primary end-points were overall survival and freedom from LVOT reintervention. Survival and freedom from reintervention were assessed using Kaplan-Meier analysis. Multivariable Cox regression was used to identify independent predictors of LVOT reintervention.</p><p><strong>Results: </strong>Seventy-seven patients underwent repair at a median age of 3 (1-8) years, with median follow-up of 9.3 (6-14) years. There was no early or late mortality; 19 patients (25%) required reintervention, including 16 (21%) LVOT-related procedures. Freedom from LVOT reintervention was 74% at 10 years and 71% at 15-20 years. Discharge LVOT velocity >3 metres per second (m/s) was independently associated with LVOT reintervention (hazard ratio [HR] 11.66, 95% confidence interval [CI] 3.56-38.18; P < .001). Younger age was also independently associated with increased risk (HR per year 0.74, 95% CI, 0.59-0.94; P = .013) for LVOT reintervention. Coronary abnormalities were documented in 17% of patients, with one early coronary reintervention.</p><p><strong>Conclusions: </strong>Surgical repair of supravalvar aortic stenosis is associated with excellent long-term survival. Residual discharge velocity emerged as an independent predictor of late LVOT reintervention, supporting the importance of achieving optimal haemodynamic relief at the index operation and structured lifelong surveillance.</p>","PeriodicalId":73406,"journal":{"name":"Interdisciplinary cardiovascular and thoracic surgery","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13730594/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148802599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Victoria Rizzo, Evgeny Raevsky, Christopher Primus, Ceri Davies, Satya Das, Cristina Suarez, Shirish Ambekar, Neil Roberts, Nandor Marczin, Rakesh Uppal, Kulvinder Lall, Simon Woldman, Thanos Athanasiou, Tayana Soukup
{"title":"Development of the First Quality Assessment Framework for the Endocarditis Multidisciplinary Team Meeting.","authors":"Victoria Rizzo, Evgeny Raevsky, Christopher Primus, Ceri Davies, Satya Das, Cristina Suarez, Shirish Ambekar, Neil Roberts, Nandor Marczin, Rakesh Uppal, Kulvinder Lall, Simon Woldman, Thanos Athanasiou, Tayana Soukup","doi":"10.1093/icvts/ivag219","DOIUrl":"10.1093/icvts/ivag219","url":null,"abstract":"<p><strong>Objectives: </strong>Endocarditis is increasing in incidence with substantial morbidity and mortality. The endocarditis multidisciplinary team (MDT) is a core guideline recommendation with clear patient outcome benefits by expediting diagnosis, coordinating investigations and management. There is significant variability in content and specialist input, with no validated metric available to assess decision-making or demonstrate improvement over time. Multidisciplinary Team Metric for the Observation of Decision-making (MDT-MODe) is a validated quality assessment tool extensively utilized for cancer MDTs. This paper describes the adaptation of the psychometrically tested MDT-MODe to an endocarditis setting, resulting in the development of MDT-MODIE (Metric for the Observation of Decision-making for Infective Endocarditis).</p><p><strong>Methods: </strong>An expert interview panel was engaged at a single high-volume London centre. Domains were assessed and analysed using a content validity index, through which the final MDT-MODIE was defined. Feasibility testing was conducted during MDTs between September 2024 and April 2025. Inter-rater reliability was assessed using intraclass correlation coefficients (ICCs), while internal validation was evaluated through point-biserial correlation coefficients. Statistical analyses were performed using IBM SPSS Statistics (version 29.0).</p><p><strong>Results: </strong>Domains scored as excellent or good were included in MDT-MODIE. Feasibility and reliability testing was performed with 152 patient discussions assessed, and scores matched to decision outcomes for each patient. Inter-rater reliability was confirmed across all domains (P < .001). Internal validation demonstrated a positive correlation between overall MODIE scores and MDT decision-making outcomes (rpb(96) = 0.216, P = .033).</p><p><strong>Conclusions: </strong>Metric for the Observation of Decision-making for Infective Endocarditis provides a reliable framework for evaluating endocarditis MDT decision-making, which has undergone preliminary validation. It addresses a key gap in the literature, supporting cardiac centres in assessing the quality of guideline-recommended MDTs and monitoring improvement over time.</p>","PeriodicalId":73406,"journal":{"name":"Interdisciplinary cardiovascular and thoracic surgery","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13730559/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148932070","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Samuel Max, Mounir Bourass, Andre van der Mee Mendes, Daniel van der Mee Mendes, Bram Schalkwijk, Zaheer Babar, Lydia Lim, Carlos Elzo Kraemer, Brian Kaufman, Antony van Dijk, Renske Brekelmans, Priscilla Westbroek, Abdelrhman Mostafa Ali, Juan Hugo, Robert Klautz, Jerry Braun, Edris Mahtab
{"title":"Building an Extracorporeal Membrane Oxygenation Digital Twin Using High-Resolution Patient Data: An Artificial Intelligence Model for Virtual Reality Simulation.","authors":"Samuel Max, Mounir Bourass, Andre van der Mee Mendes, Daniel van der Mee Mendes, Bram Schalkwijk, Zaheer Babar, Lydia Lim, Carlos Elzo Kraemer, Brian Kaufman, Antony van Dijk, Renske Brekelmans, Priscilla Westbroek, Abdelrhman Mostafa Ali, Juan Hugo, Robert Klautz, Jerry Braun, Edris Mahtab","doi":"10.1093/icvts/ivag047","DOIUrl":"10.1093/icvts/ivag047","url":null,"abstract":"<p><strong>Objectives: </strong>Extracorporeal membrane oxygenation (ECMO) is a life-saving therapy for severe cardiopulmonary failure, but structured training remains constrained by costs, logistics, and the absence of validated high-fidelity simulators. This study aimed to develop an ECMO digital twin capable of supporting training in virtual reality (VR).</p><p><strong>Methods: </strong>We integrated high-frequency ECMO machine data with electronic health record information from 335 patients across 2 centres. Data streams were synchronized at a 30-s resolution. A hierarchical 2-stage system was designed: Model 1 predicted ECMO device outputs, while Model 2 combined those outputs with patient vital functions such as heart rate and blood pressure. This model was integrated into a VR simulation and underwent testing by 21 experts.</p><p><strong>Results: </strong>Model 2 demonstrated root mean square errors (RMSEs) of 15.23 mm Hg (diastolic arterial blood pressure), 19.50 BPM (heart rate), 2.94% (peripheral oxygen saturation), and 1.42 mm Hg (end-tidal carbon dioxide) on the test set. Neural networks produced clinically coherent predictions. The models were implemented in an unreal engine-based VR simulator using the open neural network exchange format, with real-time latency inference and scenario switching. Expert testing confirmed good performance and clinically plausible physiological responses in the simulation.</p><p><strong>Conclusions: </strong>High-resolution ECMO data can be transformed into a digital twin for VR training. This framework broadens access to advanced ECMO education and establishes a foundation for multicentre validation, federated learning, and future expansion towards a critical-care digital-twin platform.</p>","PeriodicalId":73406,"journal":{"name":"Interdisciplinary cardiovascular and thoracic surgery","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13746011/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146229623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Henri-Jussi Kurvinen, Ari Mennander, Mikko Uimonen
{"title":"Surveillance After Thoracic Aortic Surgery Yields to Low Number of Reinterventions: A Retrospective Cohort Study.","authors":"Henri-Jussi Kurvinen, Ari Mennander, Mikko Uimonen","doi":"10.1093/icvts/ivag239","DOIUrl":"10.1093/icvts/ivag239","url":null,"abstract":"<p><strong>Aim: </strong>Postoperative imaging surveillance after thoracic aortic surgery is widely recommended, but its clinical yield, efficiency, and optimal targeting remain poorly defined. We aimed to quantify imaging intensity, determine the procedural yield of surveillance imaging, and assess whether follow-up strategies could be better individualized.</p><p><strong>Methods: </strong>We conducted a retrospective single-centre cohort study of patients undergoing thoracic aortic surgery between 2010 and 2024. Postoperative imaging examinations were reviewed and linked with subsequent treatment decisions. Imaging findings, reinterventions, timing of events, detection context, and follow-up patterns were analysed.</p><p><strong>Results: </strong>The cohort included 380 patients with 1757 postoperative imaging examinations, of which 1074 were classified as surveillance aortic imaging performed ≥30 days after surgery. Overall, 42 examinations led to reintervention in 29 patients (7.6%), including 13 examinations leading to aortic reoperation in 12 patients. Among surveillance aortic examinations, 41 (3.8%) led to reintervention and 16 (1.5%) met treatment thresholds without immediate intervention, yielding a combined directly or potentially actionable finding rate of 5.3%. This corresponded to 26.2 surveillance examinations per reintervention and 82.6 per aortic reoperation. Cumulative incidences of first reintervention were 2.8% at 1 year, 5.9% at 3 years, and 8.3% at 5 years. Most reinterventions were identified during elective surveillance imaging (71.4%). Despite more frequent imaging among emergency patients, reintervention risk and imaging yield were similar to those of non-emergency patients.</p><p><strong>Conclusions: </strong>Postoperative imaging surveillance after thoracic aortic surgery was associated with substantial imaging burden but low immediate procedural yield, with clinically relevant findings concentrated in a minority of patients. These findings support the need to better define patient-specific risk and imaging efficiency but do not establish that less intensive surveillance would be safe without prospective validation.</p>","PeriodicalId":73406,"journal":{"name":"Interdisciplinary cardiovascular and thoracic surgery","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13730577/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148835385","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}